REPROCELL Competitors

Stocks . Germany . 
Stock . REPROCELL
6RC Stock  EUR 0.57  0.00  0.00%   
REPROCELL competes with SALESFORCE INC, CarsalesCom, Air Lease, Lendlease, and Retail Estates; as well as few others. The company operates under Metals & Mining sector and is part of Materials industry. Analyzing REPROCELL competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of REPROCELL to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out REPROCELL Correlation with its peers.

REPROCELL vs Global Ship Correlation

Excellent diversification

The correlation between REPROCELL and 37H is -0.62 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding REPROCELL and 37H in the same portfolio, assuming nothing else is changed.

Moving together with REPROCELL Stock

  0.62HK2C Hong Kong ExchangesPairCorr

Moving against REPROCELL Stock

  0.8XMF STOMO MITSUI FINLPairCorr
  0.75XSI Sanyo Chemical IndustriesPairCorr
  0.7FPMB FREEPORT MCMORANPairCorr
  0.7SCL Schlumberger LimitedPairCorr
  0.694OQ1 AGNC Investment CorpPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.030.5712.29
Details
Intrinsic
Valuation
LowRealHigh
0.030.5612.28
Details
Naive
Forecast
LowNextHigh
0.010.5712.29
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.470.610.75
Details

REPROCELL Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between REPROCELL and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of REPROCELL and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of REPROCELL does not affect the price movement of the other competitor.

High positive correlations

LLC
+ 0.8
WN6
T2G
+ 0.66
WN6
T2G
+ 0.4
LLC
37H
+ 0.33
R6N
AVLA
+ 0.32
WN6
LLC
+ 0.31
FOO0
  

High negative correlations

37H
- 0.68
LLC
37H
- 0.66
WN6
R6N
- 0.64
FOO0
T2G
- 0.43
R6N
R6N
- 0.41
WN6
37H
- 0.37
FOO0

Risk-Adjusted Indicators

There is a big difference between REPROCELL Stock performing well and REPROCELL Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze REPROCELL's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

REPROCELL Competitive Analysis

The better you understand REPROCELL competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, REPROCELL's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across REPROCELL's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6RC GOKA FOO0 WN6 AVLA LLC R6N T2G 37H
 0.00 
 0.57 
REPROCELL
 0.00 
 0.0001 
Office
 7.33 
 8.85 
SALESFORCE
 7.27 
 15.30 
CarsalesCom
 0.93 
 54.50 
Air
 2.16 
 2.72 
Lendlease
 2.78 
 66.60 
Retail
 1.16 
 85.00 
Tradegate
 3.43 
 31.00 
Global
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Somewhat reliable
Not too volatile
Very steady
Slightly risky
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Soft
Weakest
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Strong
Low
Tiny
Small
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Hold
Cautious Hold
Cautious Hold
Strong Sell
Hold
Cautious Hold
Current Ratio
N/A
3.32
N/A
2.58
2.57
N/A
0.23
1.85
1.69
Net Asset
9.67 B
3.82 B
N/A
4.89 B
32.28 B
14.13 B
2.16 B
390.45 M
2.37 B
Profit Margin
N/A
-0.63
0.18
0.23
0.35
N/A
0.79
0.24
0.54
EBITDA
(513.85 M)
235.66 M
11.8 B
540.26 M
2.46 B
N/A
119.63 M
N/A
479 M
Current Valuation
50.54 M
1.92 B
166.56 B
6.44 B
22.82 B
3.94 B
1.88 B
2.08 B
1.35 B
Price To Book
1.15
0.012
3.02
3.27
0.86
0.64
0.8
15.99
0.77
Operating Margin
N/A
0.15
0.24
0.4
0.5
N/A
0.81
0.38
0.52
Retained Earnings
58.29 M
(1.5 B)
N/A
676.34 M
4.15 B
1.2 B
106.7 M
99.49 M
773.76 M
Five Year Return
N/A
10.71
N/A
4.04
1.13
N/A
N/A
2.55
N/A
Beta
N/A
1.55
1.28
0.74
1.13
N/A
0.62
0.014
0.88
Number Of Employees
N/A
N/A
76.45 K
2.5 K
165
N/A
43
167
7
Shares Outstanding
N/A
73.98 M
16.09 B
378.43 M
111.77 M
N/A
15.03 M
24.38 M
35.77 M
Cash Flow From Operations
6.29 M
67.17 M
N/A
203.64 M
1.68 B
N/A
95.45 M
70.71 M
430.15 M
Annual Yield
N/A
357.74
0.0085
0.0304
0.0138
0.0442
0.0787
0.014
0.0668
Total Debt
685.81 M
325 M
N/A
36.87 M
24.75 B
620 M
61.48 M
258.33 M
136.56 M
Return On Equity
N/A
-0.25
0.12
0.0978
0.13
N/A
0.0955
0.32
0.26
Return On Asset
N/A
0.0112
0.0595
0.0586
0.0278
N/A
0.0344
0.0957
0.1
Book Value Per Share
N/A
12.2
53.93
4.67
63.24
N/A
80.6
5.37
40.63
Total Asset
9.67 B
3.82 B
N/A
4.89 B
32.28 B
14.13 B
2.16 B
390.45 M
2.37 B
Debt To Equity
N/A
1.36
N/A
180.5
2.55
N/A
114.8
6.3
1.38
Target Price
N/A
29.25
N/A
N/A
54.57
N/A
N/A
16.79
23.25
Last Dividend Paid
N/A
0.03
1.65
0.8
0.88
N/A
5.1
1.2
2.13
Shares Owned By Institutions
N/A
9.91
N/A
42.19
88.29
N/A
18.16
N/A
48.35
Market Capitalization
131.36 M
7.86 K
159.48 B
5.75 B
6.14 B
13.91 B
988.74 M
2.07 B
1.09 B
Price To Earning
N/A
41.8
N/A
16.09
10.84
N/A
16.79
28.34
32.3
Price To Earnings To Growth
N/A
N/A
0.9
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
3.77
N/A
3.96
4.86
2.11
0.43
6.96
12.46
1.45
Net Income
103.25 M
(136.11 M)
N/A
275.49 M
427.7 M
N/A
106.7 M
29.39 M
353.63 M
Earnings Per Share
N/A
-4.53
0.37
0.43
7.3
N/A
7.58
1.9
7.99
Shares Owned By Insiders
N/A
1.65
N/A
5.46
5.87
N/A
24.53
96.19
10.04
Revenue
2.98 B
501.98 M
40.32 B
1.18 B
2.73 B
N/A
158.94 M
134.25 M
705.53 M
Working Capital
4.26 B
12.71 M
N/A
209.61 M
(933.45 M)
(823 M)
(56.09 M)
N/A
37.24 M
Cash And Equivalents
N/A
184.46 M
N/A
48.09 M
1.21 B
N/A
3.16 M
51.22 M
142.21 M
Cash Per Share
N/A
3.82
N/A
0.2
10.6
N/A
0.28
2.1
3.92
Gross Profit
N/A
382.67 M
31.34 B
1 B
1.7 B
N/A
125.84 M
165.71 M
519.8 M
Day Typical Price
0.57
1.0E-4
8.85
15.3
54.5
2.74
66.23
84.83
31.17
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
0.0216
0.0165
0.0059
0.0165
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
0.06
1.1
0.5
0.52
Daily Balance Of Power
0.0
0.0
0
0
9.2 T
(1.00)
1.636364
(2.00)
(2.12)
Period Momentum Indicator
N/A
N/A
(0.70)
(1.20)
0.5
(0.06)
1.8
(1.00)
(1.10)
Rate Of Daily Change
1.0
1.0
0.93
0.93
1.01
0.98
1.03
0.99
0.97
Day Median Price
0.57
1.0E-4
8.85
15.3
54.5
2.75
66.05
84.75
31.26
Price Action Indicator
N/A
N/A
(0.35)
(0.60)
0.25
(0.06)
1.45
(0.25)
(0.81)
Coefficient Of Variation
27599.07
N/A
(753.09)
(392.60)
8019.43
(733.08)
1118.31
(2,140)
634.78
Mean Deviation
2.96
N/A
2.18
1.39
0.2903
1.04
0.8061
0.3827
1.52
Jensen Alpha
0.0224
N/A
(0.40)
(0.49)
(0.01)
(0.22)
0.0921
(0.06)
0.3156
Total Risk Alpha
(0.49)
N/A
(0.54)
(0.56)
(0.03)
(0.27)
0.0365
(0.09)
0.22
Sortino Ratio
(0.0005)
N/A
N/A
N/A
(0.03)
N/A
0.0427
N/A
0.1682
Downside Variance
111.59
N/A
N/A
N/A
1.28
N/A
1.5
N/A
2.81
Standard Deviation
11.08
N/A
2.93
1.81
0.5395
1.45
1.09
0.8617
2.07
Kurtosis
39.39
N/A
0.6394
1.89
1.83
3.17
1.61
10.33
3.87
Potential Upside
3.03
N/A
3.71
2.11
0.9259
1.97
1.9
1.15
2.97
Treynor Ratio
0.136
N/A
(2.89)
(0.73)
(0.02)
(0.81)
(0.64)
(0.17)
9.13
Maximum Drawdown
119.21
N/A
14.11
6.9
2.78
7.86
5.07
6.74
13.09
Variance
122.69
N/A
8.61
3.29
0.291
2.09
1.18
0.7426
4.3
Market Risk Adjusted Performance
0.146
N/A
(2.88)
(0.72)
(0.01)
(0.80)
(0.63)
(0.16)
9.14
Risk Adjusted Performance
0.012
N/A
(0.09)
(0.19)
0.0054
(0.1)
0.0703
(0.03)
0.1248
Skewness
4.37
N/A
(0.31)
(0.89)
(0.50)
(0.74)
(0.30)
1.19
0.9307
Semi Deviation
6.04
N/A
N/A
N/A
0.4267
N/A
1.09
N/A
1.47
Information Ratio
(0.0004)
N/A
(0.15)
(0.28)
(0.07)
(0.17)
0.048
(0.1)
0.1358
Value At Risk
(4.41)
N/A
(5.50)
(3.00)
(0.92)
(2.16)
(1.59)
(1.16)
(3.43)
Expected Short fall
(9.79)
N/A
N/A
N/A
(0.88)
N/A
(0.82)
N/A
(1.94)
Downside Deviation
10.56
N/A
N/A
N/A
1.13
N/A
1.22
N/A
1.68
Semi Variance
36.48
N/A
N/A
N/A
0.1821
N/A
1.18
N/A
2.15

REPROCELL Competition Performance Charts

Five steps to successful analysis of REPROCELL Competition

REPROCELL's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by REPROCELL in relation to its competition. REPROCELL's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of REPROCELL in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact REPROCELL's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to REPROCELL, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your REPROCELL position

In addition to having REPROCELL in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SRI Sustainable Growth Thematic Idea Now

SRI Sustainable Growth
SRI Sustainable Growth Theme
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in REPROCELL Stock

REPROCELL financial ratios help investors to determine whether REPROCELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in REPROCELL with respect to the benefits of owning REPROCELL security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY